Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07186595 · ClinicalTrials.gov registry record · Phase 4
A Study to Evaluate the Safety and Effectiveness of JUVÉDERM Products in Adult Participants for the Change of Their Overall Facial Appearance
A Phase 4 study of Mid Face Volume Deficit, sponsored by AbbVie.
- Active
- Registry status
- Phase 4
- Development phase
- 75
- Enrollment target
- 10
- Study locations
NCT07186595 is a Phase 4 study of Mid Face Volume Deficit that is active but no longer recruiting, run by AbbVie. The registered enrollment target is 75 participants. The trial reports 10 study locations across 7 states.
The verdict
NCT07186595, a Phase 4 study of Mid Face Volume Deficit, is active but no longer recruiting, sponsored by AbbVie.
- ACTIVE NOT RECRUITING
- Registry status
- Phase 4
- Development phase
- 75 participants
- Enrollment target
- 10
- Study locations
Study Summary
The purpose of this study is to evaluate the safety and effectiveness of JUVÉDERM products in adults seeking improvement in facial volume and/or skin quality.
Conditions Studied
Interventions
- DEVICE JUVÉDERM VOLUX XC
- DEVICE JUVÉDERM VOLUMA XC
- DEVICE JUVÉDERM VOLBELLA XC
- DEVICE JUVÉDERM VOLLURE XC
- DEVICE SKINVIVE by JUVÉDERM
Study Locations (10)
California
- Kian Aesthetic Institute /ID# 277045 - Los Angeles
- West Dermatology La Jolla /ID# 277034 - San Diego
- Pacific Clinical Innovations /ID# 277026 - Vista
Louisiana
- H&H Research, LLC /ID# 277084 - Metairie
- DelRicht Research - New Orleans 308 /ID# 277039 - New Orleans
Florida
- Skin Research Institute LLC /ID# 277038 - Coral Gables
Georgia
- Monarch Plastic Surgery and Skin Renewal Center /ID# 278182 - Atlanta
Illinois
- Advanced Dermatology - Lincolnshire /ID# 277036 - Lincolnshire
Texas
- Bellaire Dermatology Associates /ID# 278180 - Bellaire
Virginia
- SkinDC /ID# 277062 - Arlington
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 75 participants |
| Start Date | 2025-09-25 |
| Est. Completion | 2026-08 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07186595
The ClinicalTrials.gov registry entry for NCT07186595 describes a study currently listed as active not recruiting, categorized as Phase 4. The registered enrollment target is 75 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is AbbVie, which has 526 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Mid Face Volume Deficit appearing as the primary indexed condition, and to 5 interventions - of which JUVÉDERM VOLUX XC is the first listed.
NCT07186595 reports 10 study locations spanning 7 distinct geographic areas - top geographies include California, Louisiana, Florida.
Frequently Asked Questions
What is clinical trial NCT07186595 about?
NCT07186595 is a clinical study titled "A Study to Evaluate the Safety and Effectiveness of JUVÉDERM Products in Adult Participants for the Change of Their Overall Facial Appearance". The purpose of this study is to evaluate the safety and effectiveness of JUVÉDERM products in adults seeking improvement in facial volume and/or skin quality.
What is the current status of trial NCT07186595?
This trial is currently active not recruiting. It is a Phase 4 study. The enrollment target is 75 participants. The study started on 2025-09-25. Estimated completion is 2026-08.
What conditions does trial NCT07186595 study?
This clinical trial studies the following conditions: Mid Face Volume Deficit.
What interventions are being tested in trial NCT07186595?
The interventions under investigation include: JUVÉDERM VOLUX XC (DEVICE), JUVÉDERM VOLUMA XC (DEVICE), JUVÉDERM VOLBELLA XC (DEVICE), JUVÉDERM VOLLURE XC (DEVICE), SKINVIVE by JUVÉDERM (DEVICE).
Who is sponsoring clinical trial NCT07186595?
This trial is sponsored by AbbVie, which has 526 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07186595 being conducted?
This trial has 10 study locations across California, Florida, Georgia, Illinois, Louisiana. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Mid Face Volume Deficit
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.